Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity
Gregory F. Wu(University of Pennsylvania), Terri M. Laufer(Philadelphia VA Medical Center), Tom L. Stephen(University of Pennsylvania), Eric J. Allenspach(University of Washington), Anne H. Cross(Washington University in St. Louis), Robert Mikesell(Meharry Medical College), Hannah Thomas(University of Pennsylvania), Kenneth S. Shindler(Penn Presbyterian Medical Center)
Cited by 52
Related Papers
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|857
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
MHC class II–dependent basophil–CD4+ T cell interactions promote TH2 cytokine–dependent immunity
|Nature Immunology|2009|590
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
|Molecular Therapy|2009|551
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
|Science Translational Medicine|2012|390